1. Home
  2. RGS vs ATNM Comparison

RGS vs ATNM Comparison

Compare RGS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$28.22

Market Cap

70.8M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.61

Market Cap

47.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGS
ATNM
Founded
1922
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.8M
47.1M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
RGS
ATNM
Price
$28.22
$1.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
7.1K
163.1K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
20.05
N/A
EPS
45.08
N/A
Revenue
$223,032,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$42,943.57
P/E Ratio
$0.65
N/A
Revenue Growth
13.98
11.11
52 Week Low
$15.00
$1.03
52 Week High
$31.50
$2.41

Technical Indicators

Market Signals
Indicator
RGS
ATNM
Relative Strength Index (RSI) 48.35 62.85
Support Level $28.54 $1.48
Resistance Level $30.17 $1.69
Average True Range (ATR) 0.80 0.09
MACD 0.05 0.02
Stochastic Oscillator 40.11 75.00

Price Performance

Historical Comparison
RGS
ATNM

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: